Literature DB >> 22419664

Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma.

Cédric Coulouarn1, Anne Corlu, Denise Glaise, Isabelle Guénon, Snorri S Thorgeirsson, Bruno Clément.   

Abstract

Many solid malignant tumors arise on a background of inflamed and/or fibrotic tissues, features that are found in more than 80% hepatocellular carcinomas (HCC). Activated hepatic stellate cells (HSC) play a critical role in fibrogenesis associated with HCC onset and progression, yet their functional impact on hepatocyte fate remains largely unexplored. Here, we used a coculture model to investigate the cross-talk between hepatocytes (human hepatoma cells) and activated human HSCs. Unsupervised genome-wide expression profiling showed that hepatocyte-HSC cross-talk is bidirectional and results in the deregulation of functionally relevant gene networks. Notably, coculturing increased the expression of proinflammatory cytokines and modified the phenotype of hepatocytes toward motile cells. Hepatocyte-HSC cross-talk also generated a permissive proangiogenic microenvironment, particularly by inducing VEGFA and matrix metalloproteinase (MMP)9 expression in HSCs. An integrative genomic analysis revealed that the expression of genes associated with hepatocyte-HSC cross-talk correlated with HCC progression in mice and was predictive of a poor prognosis and metastasis propensity in human HCCs. Interestingly, the effects of cross-talk on migration and angiogenesis were reversed by the histone deacetylase inhibitor trichostatin A. Our findings, therefore, indicate that the cross-talk between hepatoma cells and activated HSCs is an important feature of HCC progression, which may be targeted by epigenetic modulation. ©2012 AACR.

Entities:  

Mesh:

Year:  2012        PMID: 22419664      PMCID: PMC3498759          DOI: 10.1158/0008-5472.CAN-11-3317

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  45 in total

1.  Molecular pathogenesis of human hepatocellular carcinoma.

Authors:  Snorri S Thorgeirsson; Joe W Grisham
Journal:  Nat Genet       Date:  2002-08       Impact factor: 38.330

2.  Increased extracellular matrix remodeling is associated with tumor progression in human hepatocellular carcinomas.

Authors:  N Théret; O Musso; B Turlin; D Lotrian; P Bioulac-Sage; J P Campion; K Boudjéma; B Clément
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

3.  Patterns of intermediate filaments, VLA integrins and HLA antigens in a new human biliary epithelial cell line sensitive to interferon-gamma.

Authors:  S Rumin; O Loréal; B Drénou; B Turlin; M Rissel; J P Campion; P Gripon; A J Strain; B Clément; C Guguen-Guillouzo
Journal:  J Hepatol       Date:  1997-06       Impact factor: 25.083

4.  Cooperation of Ito cells and hepatocytes in the deposition of an extracellular matrix in vitro.

Authors:  O Loréal; F Levavasseur; C Fromaget; D Gros; A Guillouzo; B Clément
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

5.  A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture.

Authors:  T Niki; K Rombouts; P De Bleser; K De Smet; V Rogiers; D Schuppan; M Yoshida; G Gabbiani; A Geerts
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

6.  Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and tumor growth in cells carrying active β-catenin.

Authors:  E Lavergne; I Hendaoui; C Coulouarn; C Ribault; J Leseur; P-A Eliat; S Mebarki; A Corlu; B Clément; O Musso
Journal:  Oncogene       Date:  2010-09-20       Impact factor: 9.867

7.  Activation of matrix metalloproteinase-2 from hepatic stellate cells requires interactions with hepatocytes.

Authors:  N Théret; O Musso; A L'Helgoualc'h; B Clément
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

8.  Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling.

Authors:  Ju-Seog Lee; In-Sun Chu; Jeonghoon Heo; Diego F Calvisi; Zongtang Sun; Tania Roskams; Anne Durnez; Anthony J Demetris; Snorri S Thorgeirsson
Journal:  Hepatology       Date:  2004-09       Impact factor: 17.425

9.  TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia.

Authors:  Neil A Bhowmick; Anna Chytil; David Plieth; Agnieszka E Gorska; Nancy Dumont; Scott Shappell; M Kay Washington; Eric G Neilson; Harold L Moses
Journal:  Science       Date:  2004-02-06       Impact factor: 47.728

Review 10.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

View more
  70 in total

Review 1.  Targeting the tumor stroma in hepatocellular carcinoma.

Authors:  Femke Heindryckx; Pär Gerwins
Journal:  World J Hepatol       Date:  2015-02-27

2.  Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation.

Authors:  Cristina Bárcena; Milica Stefanovic; Anna Tutusaus; Leonel Joannas; Anghara Menéndez; Carmen García-Ruiz; Pau Sancho-Bru; Montserrat Marí; Joan Caballeria; Carla V Rothlin; José C Fernández-Checa; Pablo García de Frutos; Albert Morales
Journal:  J Hepatol       Date:  2015-04-20       Impact factor: 25.083

3.  Integrative Genomic Analysis Identifies the Core Transcriptional Hallmarks of Human Hepatocellular Carcinoma.

Authors:  Coralie Allain; Gaëlle Angenard; Bruno Clément; Cédric Coulouarn
Journal:  Cancer Res       Date:  2016-09-12       Impact factor: 12.701

4.  The SDF-1/CXCR4 axis induces epithelial–mesenchymal transition in hepatocellular carcinoma.

Authors:  Xuqi Li; Pei Li; Yuanhong Chang; Qinhong Xu; Zheng Wu; Qingyong Ma; Zheng Wang
Journal:  Mol Cell Biochem       Date:  2014-07       Impact factor: 3.396

5.  IL-17 and TNF-α co-operation contributes to the proinflammatory response of hepatic stellate cells.

Authors:  A Beringer; P Miossec
Journal:  Clin Exp Immunol       Date:  2019-06-06       Impact factor: 4.330

6.  Connective tissue growth factor is overexpressed in human hepatocellular carcinoma and promotes cell invasion and growth.

Authors:  Ming Xiu; Ya-Hui Liu; David R Brigstock; Fang-Hui He; Rui-Juan Zhang; Run-Ping Gao
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

7.  Optimization of collagen type I-hyaluronan hybrid bioink for 3D bioprinted liver microenvironments.

Authors:  Andrea Mazzocchi; Mahesh Devarasetty; Richard Huntwork; Shay Soker; Aleksander Skardal
Journal:  Biofabrication       Date:  2018-10-30       Impact factor: 9.954

Review 8.  Functional and genetic deconstruction of the cellular origin in liver cancer.

Authors:  Jens U Marquardt; Jesper B Andersen; Snorri S Thorgeirsson
Journal:  Nat Rev Cancer       Date:  2015-11       Impact factor: 60.716

9.  Hepatitis C virus infection induces inflammatory cytokines and chemokines mediated by the cross talk between hepatocytes and stellate cells.

Authors:  Hironori Nishitsuji; Kenji Funami; Yuko Shimizu; Saneyuki Ujino; Kazuo Sugiyama; Tsukasa Seya; Hiroshi Takaku; Kunitada Shimotohno
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

Review 10.  Translational approaches: from fatty liver to non-alcoholic steatohepatitis.

Authors:  Natalia Rosso; Norberto C Chavez-Tapia; Claudio Tiribelli; Stefano Bellentani
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.